Knockdown of ADORA2A antisense RNA 1 inhibits cell proliferation and enhances imatinib sensitivity in chronic myeloid leukemia

References

• Cagnetta A, Garuti A, Marani C, et al. Evaluating treatment response of chronic myeloid leukemia: emerging science and technology. Curr Cancer Drug Targets. 2013;13(7):779–790.
   PubMed Web of Science ®Google Scholar
• Zhou H, Xu R. Leukemia stem cells: the root of chronic myeloid leukemia. Protein Cell. 2015;6(6):403–412.
   PubMed Web of Science ®Google Scholar
• Shanmuganathan N, Hiwase DK, Ross DM, et al. Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome. Leukemia Lymphoma. 2017;58(12):2799–2810.
   PubMed Web of Science ®Google Scholar
• Sobhia M, Kumar GS, Mallick A, et al. Computational and biological investigations on Abl1 tyrosine kinase: a review. Current Drug Targets. 2020;22(1):38–51.
   Web of Science ®Google Scholar
• Zhang X, Wang, W, Zhu, W, et al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int J Mol Sci 2019;20(22): 5573.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu S, Tang L, et al. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9). Bioengineered. 2021;12(1):162–171.
   PubMed Web of Science ®Google Scholar
• Feng Y, Wei G, Zhang L, et al. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Bioengineered. 2021;12(1):8217–8232.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen K, Guo G, et al. Noncoding RNAs and their functional involvement in regulation of chronic myeloid leukemia. Briefings Funct Genomics. 2016;15(3):239–248.
   PubMed Web of Science ®Google Scholar
• Guo G, Kang Q, Zhu X, et al. A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA. Oncogene. 2015;34(14):1768–1779.
   PubMed Web of Science ®Google Scholar
• Yang J, Yin Z, Li Y, et al. The identification of long non-coding RNA H19 target and its function in chronic myeloid leukemia. Mol Ther Nucleic Acids. 2020;19:1368–1378.
   PubMedGoogle Scholar
• Zhang F, Ni H, Li X, et al. LncRNA FENDRR attenuates Adriamycin resistance via suppressing MDR1 expression through sponging HuR and miR-184 in chronic myelogenous leukaemia cells. FEBS Letters. 2019;593(15):1993–2007.
   PubMed Web of Science ®Google Scholar
• Matoba N, Akiyama M, Ishigaki K, et al. GWAS of 165,084 Japanese individuals identified nine loci associated with dietary habits. Nat Human Behav. 2020;4(3):308–316.
   PubMed Web of Science ®Google Scholar
• Sun M, Chen Y, Liu X, et al. LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling. Bioengineered. 2021;12(1):8006–8019.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zeng J, Xia H, et al. Upregulated lncRNA Cyclin-dependent kinase inhibitor 2B antisense RNA 1 induces the proliferation and migration of colorectal cancer by miR-378b/CAPRIN2 axis. Bioengineered. 2021;12(1):5476–5490.
   PubMed Web of Science ®Google Scholar
• Zhang M, Yang L, Hou L, et al. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer. Bioengineered. 2021;12(2):9239–9250.
   PubMed Web of Science ®Google Scholar
• Li J, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92–7.
   PubMed Web of Science ®Google Scholar
• Zhou B, Guo W, Sun C, et al. Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway. Cell Death Dis. 2018;9(6):706.
   PubMedGoogle Scholar
• Cao L, Jin H, Zheng Y, et al. DANCR-mediated microRNA-665 regulates proliferation and metastasis of cervical cancer through the ERK/SMAD pathway. Cancer Sci. 2019;110(3):913–925.
   PubMed Web of Science ®Google Scholar
• He B, Bai Y, Kang W, et al. LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p. Am J Cancer Res. 2017;7(8):1704–1713.
   PubMed Web of Science ®Google Scholar
• Bennour A, Saad A, Sennana H. Chronic myeloid leukemia: relevance of cytogenetic and molecular assays. Crit Rev Oncol Hematol. 2016;97:263–274.
   PubMed Web of Science ®Google Scholar
• Massimino M, Stella S, Tirrò E, et al. ABL1-Directed Inhibitors for CML: efficacy, resistance and future perspectives. Anticancer Res. 2020;40(5):2457–2465.
   PubMed Web of Science ®Google Scholar
• Yang J, Shi M-X, Zeng Y, et al. LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells by sponging with micRNA-1275. Eur Rev Med Pharmacol Sci. 2019;23(5):2103–2111.
   PubMed Web of Science ®Google Scholar
• Li Z, Luo J. Epigenetic regulation of HOTAIR in advanced chronic myeloid leukemia. Cancer Manage Res. 2018;10:5349–5362.
   PubMed Web of Science ®Google Scholar
• Zeng C, Liu S, Lu S, et al. The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells. Mol Cancer. 2018;17(1):130.
   PubMedGoogle Scholar
• Lin W, Liu H, Tang Y, et al. The development and controversy of competitive endogenous RNA hypothesis in non-coding genes. Mol Cell Biochem. 2021;476(1):109–123.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang S, Yi A, et al. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A. Cell Biochem Funct. 2020;38(4):409–418.
   PubMed Web of Science ®Google Scholar
• Zhou P, Xiong T, Yao L, et al. MicroRNA-665 promotes the proliferation of ovarian cancer cells by targeting SRCIN1. Exp Ther Med. 2020;19(2):1112–1120.
   PubMed Web of Science ®Google Scholar
• Zhao X, Hu J-Y, Tang J, et al. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer. Cell Death Dis. 2019;10(7):479.
   PubMedGoogle Scholar
• Xin J, Zhao, Y, Zhang, X, et al. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis. Hum Cell 2020;33(4):1273–1280.
   PubMed Web of Science ®Google Scholar
• Bai N, Peng E, Xia F, et al. CircABCC2 regulates hepatocellular cancer progression by decoying MiR-665. J Cancer. 2019;10(17):3893–3898.
   PubMed Web of Science ®Google Scholar
• Møller G, Frost, V, Melo, J, et al. Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemia. FEBS Lett. 2007;581(7):1329–1334.
   PubMed Web of Science ®Google Scholar
• Zhu J, Luo, Y, Zhao, Y, et al. circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p/TGFβR1/VEGF-D signaling. Mol Ther. 2021;29:1838–1852.
   PubMed Web of Science ®Google Scholar
• Lei B, Wang, D, Zhang, M, et al. miR-615-3p promotes the epithelial-mesenchymal transition and metastasis of breast cancer by targeting PICK1/TGFBRI axis. J Exp Clin Cancer Res. 2020;39(1):71.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang Y, Yang H, et al. TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562/G01 cells by neutralizing the Wnt/β-catenin/TCF7/ABC transporter signaling axis. Oncol Rep. 2020;45:557–568.
   PubMed Web of Science ®Google Scholar
• Gupta S, Singh P, Ali V, et al. Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy. Oncol Rev. 2020;14(2):448.
   PubMed Web of Science ®Google Scholar
• A study on the gastrointestinal disease and helicobacter pylori controlled long non-coding RNA. https://ClinicalTrials.gov/show/NCT03057171.
   Google Scholar
• TA(E)C-GP Versus A(E)C-T for the high risk TNBC patients and validation of the mRNA-lncRNA Signature. https://ClinicalTrials.gov/show/NCT02641847.
   Google Scholar